Santos Bourbon (Coffea arabica)

Santos Bourbon is a historic Coffea arabica cultivar originating from Bourbon Island (now Réunion), introduced to Brazil in the 18th century and later becoming foundational to Brazilian coffee production. Its primary bioactive compounds are caffeine (a methylxanthine adenosine receptor antagonist) and chlorogenic acids (polyphenolic antioxidants), shared with other arabica varieties but expressed in concentrations shaped by its specific genetic lineage and growing conditions.

Origin & History

Santos Bourbon is a Brazilian variety of Bourbon Arabica coffee (Coffea arabica) that developed naturally on Île Bourbon (now Réunion) in the Indian Ocean before being brought to Brazil. It is characterized by oval dark green leaves, round red fruit, and medium-sized beans with a distinctive nutty, caramel-sweet, full-bodied flavor profile.

Historical & Cultural Context

Santos Bourbon coffee originated as a natural mutation on Île Bourbon (Réunion) and was subsequently cultivated in Brazil where it became a prominent coffee variety. Traditional use information is limited to its role as a beverage coffee rather than a medicinal supplement.

Health Benefits

• No clinical health benefits documented - the available research only describes agricultural and sensory characteristics
• No evidence quality can be assigned due to absence of biomedical studies
• No therapeutic effects have been studied in human trials
• No standardized extract specifications exist for clinical use
• No peer-reviewed medical literature was found in the research dossier

How It Works

Caffeine, the principal alkaloid in Santos Bourbon coffee, competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing adenosine-mediated inhibition and increasing dopaminergic and noradrenergic signaling. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit glucose-6-phosphatase activity and modulate AMPK pathways, potentially influencing postprandial glucose metabolism. Diterpenes such as cafestol and kahweol, present in unfiltered preparations, activate pregnane X receptor (PXR) and affect cholesterol biosynthesis via LDL receptor downregulation.

Scientific Research

No clinical trials, meta-analyses, or biomedical studies were found in the research dossier. The available information consists only of agricultural descriptions and sensory profiles without any PMIDs or clinical evidence.

Clinical Summary

No clinical trials have been conducted specifically on Santos Bourbon as a distinct cultivar; all available research describes its agronomic traits, cup profile, and genetic classification rather than therapeutic outcomes. General Coffea arabica research, which may be tangentially applicable, includes large epidemiological cohort studies (e.g., the EPIC cohort, n>400,000) associating habitual coffee consumption with reduced risk of type 2 diabetes and certain liver conditions, though cultivar-specific contributions cannot be isolated. The absence of any biomedical study design—randomized controlled trials, observational studies, or even in vitro assays—targeting Santos Bourbon specifically means no evidence quality rating can be assigned to this cultivar. Consumers should not extrapolate generic coffee research findings as validated health claims for Santos Bourbon.

Nutritional Profile

Santos Bourbon is a cultivar of Coffea arabica and, as roasted coffee beans or brewed coffee, shares the general nutritional and phytochemical profile of arabica coffee. No cultivar-specific compositional analyses distinguishing Santos Bourbon from other arabica cultivars were identified in peer-reviewed literature; therefore, the following values are based on standard Coffea arabica data. **Brewed coffee (per 240 mL/8 fl oz, black):** Energy: ~2–5 kcal; Protein: ~0.3 g; Fat: ~0.05 g (trace lipids including cafestol and kahweol, largely removed by paper filtration); Carbohydrates: ~0 g (negligible soluble carbohydrates). **Key bioactive compounds (per 240 mL brewed):** Caffeine: ~80–100 mg (arabica generally lower than robusta; Bourbon cultivars tend toward the lower-mid range, ~1.0–1.2% dry weight in green beans); Chlorogenic acids (primarily 5-O-caffeoylquinic acid): ~70–200 mg (significant degradation during roasting; medium roast retains ~50–70% of green bean CGA content; bioavailability ~33% after gut microbial metabolism to caffeic acid and ferulic acid); Trigonelline: ~40–55 mg (partially converted to niacin/nicotinic acid during roasting, contributing ~1–2 mg niacin equivalents per cup); Diterpenes (cafestol: ~0.2–0.6 mg; kahweol: ~0.2–0.6 mg in filtered coffee; up to ~4–8 mg each in unfiltered preparations). **Minerals per 240 mL:** Potassium: ~116 mg (~2.5% DV); Magnesium: ~7 mg (~2% DV); Manganese: ~0.05 mg (~2% DV); Phosphorus: ~7 mg; Niacin (B3): ~0.5 mg plus roasting-derived niacin from trigonelline (~1–2 mg total, ~10% DV); Riboflavin (B2): ~0.18 mg (~14% DV); Pantothenic acid (B5): ~0.6 mg (~12% DV). **Other phytochemicals in green/roasted beans:** Melanoidins (Maillard reaction products formed during roasting): ~25–30% of dry weight of roasted beans; these act as dietary fiber analogs and antioxidant carriers with moderate colonic bioavailability. Total polyphenol content (as gallic acid equivalents): ~200–550 mg per cup depending on roast level and extraction. **Amino acids:** Free amino acids are largely consumed during roasting; residual protein is mostly insoluble and not extracted into brewed coffee. **Fiber:** Brewed coffee contains negligible conventional dietary fiber, though melanoidins may exert prebiotic-like effects. **Bioavailability notes:** Caffeine is nearly 100% bioavailable with rapid GI absorption (Tmax ~30–60 min). Chlorogenic acids are ~33% bioavailable; the majority reach the colon where microbial esterases release caffeic and quinic acids. Diterpene bioavailability is moderate but highly dependent on brewing method (unfiltered > filtered). Mineral bioavailability from coffee is generally low due to polyphenol chelation. No Santos Bourbon-specific clinical or compositional studies were found; all values are extrapolated from general Coffea arabica literature.

Preparation & Dosage

No clinically studied dosage ranges exist for Santos Bourbon coffee as a therapeutic agent. No standardized extract preparations have been documented in medical literature. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Santos Bourbon coffee carries the same safety profile as other Coffea arabica preparations; caffeine consumption above 400 mg/day in healthy adults is associated with insomnia, tachycardia, anxiety, and elevated blood pressure in sensitive individuals. Caffeine inhibits CYP1A2 enzyme activity and can elevate plasma concentrations of drugs metabolized by this pathway, including clozapine, theophylline, and certain antidepressants. Pregnant individuals are advised to limit caffeine intake to under 200 mg/day due to associations with low birth weight and increased miscarriage risk reported in meta-analyses. Individuals with cardiac arrhythmias, severe hypertension, anxiety disorders, or those taking MAO inhibitors should consult a physician before regular consumption.